Norway fish health group Aqua Pharma acquires 50% stake in Scottish sea lice treatment startup

Sea lice is a continuous challenge in the aquaculture industry.

Aqua Pharma is extending its reach -- and its battle against sea lice -- with the acquisition of a Scottish startup. — Aqua Pharma is extending its reach -- and its battle against sea lice -- with the acquisition of a Scottish startup.Foto: Aqua Pharma

Demi Korban

Published 15 May 2020, 12:15Updated 4 June 2020, 15:57

Farmed salmon Sea lice Fish health Mergers & Acquisitions Norway